These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19556817)

  • 1. Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastases.
    Wilop S; Dada R; Galm O; Jousten P; Osieka R; Jost E
    Onkologie; 2009 Jul; 32(7):400-4. PubMed ID: 19556817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
    Melichar B; Voboril Z; Lojík M; Krajina A
    Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
    Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
    Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors.
    Nitta N; Ohta S; Tanaka T; Takazakura R; Toyama T; Sonoda A; Seko A; Furukawa A; Takahashi M; Murata K; Kurumi Y; Tani T; Sakamoto T; Tabata Y
    Eur J Radiol; 2009 Sep; 71(3):519-26. PubMed ID: 18617345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F
    Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
    van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.
    Chiappa A; Bertani E; Makuuchi M; Zbar AP; Contino G; Viale G; Pruneri G; Bellomi M; Della Vigna P; Zampino MG; Fazio N; Travaini ML; Trifirò G; Corbellini C; Andreoni B
    Hepatogastroenterology; 2009; 56(91-92):829-34. PubMed ID: 19621711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
    Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
    Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
    Grenader T; Goldberg A; Gabizon A
    Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer.
    Li M; Zhang J; Wang D; Zhong B; Tucker S; Lu C; Cheng J; Cao C; Xu J; Xu J; Pan H
    Anticancer Drugs; 2009 Nov; 20(10):941-5. PubMed ID: 19745719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
    Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
    Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
    Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F
    Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study.
    Fiorica JV; Blessing JA; Puneky LV; Secord AA; Hoffman JS; Yamada SD; Buekers TE; Bell J; Schilder JM;
    Gynecol Oncol; 2009 Nov; 115(2):285-9. PubMed ID: 19726073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/IIa study of combination chemotherapy with CKD-602 and cisplatin in patients with recurrent epithelial ovarian cancer.
    Kim HS; Kang SB; Seo SS; Han SS; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():627-34. PubMed ID: 19723113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lymphoma metastasis presenting with severe acute liver failure: a rare case.
    Kanbay M; Gür G; Korkmaz M; Demirci B; Boyacioğlu S
    Turk J Gastroenterol; 2004 Jun; 15(2):94-6. PubMed ID: 15334318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.